← Open Payments lookup

SHALETA INGRAM: Open Payments

NPI 1710519277 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$476 in 27 payments from 9 companies in 2025. Trend: 2023 $1,395 · 2024 $1,263 · 2025 $476

Food & beverage: $476
CompanyPaymentsAmount
Novo Nordisk Inc10$149
Bayer Healthcare Pharmaceuticals Inc.4$77
Dexcom, Inc.3$68
PFIZER INC.3$57
AstraZeneca Pharmaceuticals LP3$48
IDORSIA PHARMACEUTICALS US INC1$23
ABBVIE INC.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Xeris Pharmaceuticals, Inc.1$15

Products named: Ozempic, Kerendia, Dexcom G6 Transmitter, ELIQUIS, BREZTRI, Quviviq, Rybelsus, UBRELVY.

Industry payments across TX — which companies pay providers there.